This is a legitimate pharmacological route for the right compounds
BPC-157 may indirectly support weight loss, but it is not known to directly cause fat loss
Any change runs through formal rulemaking that could take many months
NACP/alph-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains
For example, post-acquisition administration of PregS is associated with improved retention in rodents on a passive avoidance paradigm, indicating that this positive modulator of glutamatergic neurotransmission facilitates consolidation (206)
In summary, this effect may be the cause or a consequence of the beneficial effects of BPC 157 on related disturbances [1,2,3,4,5,6,7,8,9,10,11]